Diagnostic strategy of early stage pancreatic cancer via clinical predictor assessment: clinical indicators, risk factors and imaging findings

HIGHLIGHTS

• who: Ryota Sagami et al. from the Department of Gastroenterology, Oita San-ai Medical Center, Oaza Ichi, Oita, JapanDepartment of Gastroenterology, Faculty of Medicine, Oita University, Idaigaoka, Hasamacho have published the research work: Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings, in the Journal: Diagnostics 2022, 12, 377. of /2022/
• what: Commonly atypical symptoms, such as weight loss and abdominal pain, might lead to a delay in diagnosis; therefore, these clinical indicators may be the first reason to consider early stage PDAC diagnosis. In this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.